Krumholz H M, Seeman T E, Merrill S S, Mendes de Leon C F, Vaccarino V, Silverman D I, Tsukahara R, Ostfeld A M, Berkman L F
Department of Internal Medicine, Yale University School of Medicine, New Haven, CT 06520-8017.
JAMA. 1994 Nov 2;272(17):1335-40.
To determine whether elevated serum cholesterol level is associated with all-cause mortality, mortality from coronary heart disease, or hospitalization for acute myocardial infarction and unstable angina in persons older than 70 years. Also, to evaluate the association between low levels of high-density lipoprotein cholesterol (HDL-C) and elevated ratio of serum cholesterol to HDL-C with these outcomes.
Prospective, community-based cohort study with yearly interviews.
A total of 997 subjects who were interviewed in 1988 as part of the New Haven, Conn, cohort of the Established Population for the Epidemiologic Study of the Elderly (EPESE) and consented to have blood drawn.
The risk factor-adjusted odds ratios of the 4-year incidence of all-cause mortality, mortality from coronary heart disease, and hospitalization for myocardial infarction or unstable angina were calculated for the following: subjects with total serum cholesterol levels greater than or equal to 6.20 mmol/L (> or = 240 mg/dL) compared with subjects with cholesterol levels less than 5.20 mmol/L (< 200 mg/dL); subjects in the lowest tertile of HDL-C level compared with those in the highest tertile; and subjects in the highest tertile of the ratio of total serum cholesterol to HDL-C level compared with those in the lowest tertile.
Elevated total serum cholesterol level, low HDL-C, and high total serum cholesterol to HDL-C ratio were not associated with a significantly higher rate of all-cause mortality, coronary heart disease mortality, or hospitalization for myocardial infarction or unstable angina after adjustment for cardiovascular risk factors. The risk factor-adjusted odds ratio for all-cause mortality was 0.99 (95% confidence interval [CI], 0.56 to 2.69) for the group who had cholesterol levels greater than or equal to 6.20 mmol/L (> or = 240 mg/dL) compared with the group that had levels less than 5.20 mmol/L (< 200 mg/dL); 1.00 (95% CI, 0.59 to 1.70) for the group in the lowest tertile of HDL-C compared with those in the highest tertile; and 1.03 (95% CK, 0.62 to 1.71) for subjects in the highest tertile of the ratio of total serum cholesterol to HDL-C compared with those in the lowest tertile.
Our findings do not support the hypothesis that hypercholesterolemia or low HDL-C are important risk factors for all-cause mortality, coronary heart disease mortality, or hospitalization for myocardial infarction or unstable angina in this cohort of persons older than 70 years.
确定血清胆固醇水平升高是否与70岁以上人群的全因死亡率、冠心病死亡率或急性心肌梗死及不稳定型心绞痛住院率相关。此外,评估高密度脂蛋白胆固醇(HDL-C)水平低和血清胆固醇与HDL-C比值升高与这些结局之间的关联。
基于社区的前瞻性队列研究,每年进行访谈。
1988年作为康涅狄格州纽黑文市老年人流行病学研究既定人群队列研究(EPESE)的一部分接受访谈并同意抽血的997名受试者。
计算以下情况的全因死亡率、冠心病死亡率以及心肌梗死或不稳定型心绞痛住院率4年发病率的风险因素调整比值比:血清总胆固醇水平大于或等于6.20 mmol/L(≥240 mg/dL)的受试者与胆固醇水平低于5.20 mmol/L(<200 mg/dL)的受试者相比;HDL-C水平处于最低三分位数的受试者与处于最高三分位数的受试者相比;血清总胆固醇与HDL-C比值处于最高三分位数的受试者与处于最低三分位数的受试者相比。
在调整心血管风险因素后,血清总胆固醇水平升高、HDL-C水平低以及血清总胆固醇与HDL-C比值高与全因死亡率、冠心病死亡率或心肌梗死或不稳定型心绞痛住院率显著升高无关。血清总胆固醇水平大于或等于6.20 mmol/L(≥240 mg/dL)的组与低于5.20 mmol/L(<200 mg/dL)的组相比,全因死亡率的风险因素调整比值比为0.99(95%置信区间[CI]为0.56至2.69);HDL-C处于最低三分位数的组与处于最高三分位数的组相比为1.00(95%CI为0.59至1.70);血清总胆固醇与HDL-C比值处于最高三分位数的受试者与处于最低三分位数的受试者相比为1.03(95%CI为0.62至1.71)。
我们的研究结果不支持高胆固醇血症或低HDL-C是该70岁以上人群队列中全因死亡率、冠心病死亡率或心肌梗死或不稳定型心绞痛住院率的重要风险因素这一假设。